Use of antibiotics and risk of type 2 diabetes: A population-based case-control study

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 10, 2015, Pages 3633-3640

  Mikkelsen, Kristian Hallundbæk ^a,b   Knop, Filip Krag ^a,b   Frost, Morten ^c,d   Hallas, Jesper ^d   Pottegard, Anton ^d  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Capital Region   (Denmark)

^c KOLDING HOSPITAL   (Denmark)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERICIDE; BACTERIOSTATIC ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; BETA LACTAMASE RESISTANT PENICILLIN DERIVATIVE; BETA LACTAMASE SENSITIVE PENICILLIN DERIVATIVE; BROAD SPECTRUM ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; EXTENDED SPECTRUM PENICILLIN DERIVATIVE; FUSIDIC ACID; LINEZOLID; MACROLIDE; METRONIDAZOLE; NARROW SPECTRUM ANTIBIOTIC AGENT; NITROFURANTOIN DERIVATIVE; ORAL ANTIDIABETIC AGENT; PENICILLIN DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLONE DERIVATIVE; SHORT ACTING DRUG; STEROID ANTIBACTERIAL AGENT; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM; TRIMETHOPRIM DERIVATIVE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EXPOSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION BASED CASE CONTROL STUDY; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK ASSESSMENT; AGED; CASE CONTROL STUDY; DENMARK; DIABETES MELLITUS, TYPE 2; INCIDENCE; MIDDLE AGED; REGISTER; RISK;

AGED; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; DENMARK; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; REGISTRIES; RISK;

EID: 84943793548     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-2696     Document Type: Article

References (40)

1. Xu J, Gordon JI. Honor thy symbionts. Proc Natl Acad Sci. 2003; 100(18):10452-10459.
2. Qin J, Li Y, Cai Z, et al.Ametagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55-60.
3. Karlsson FH, Tremaroli V, Nookaew I, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498(7452):99-103.
4. Ridaura VK, Faith JJ, Rey FE, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013; 341(6150):1241214.
5. Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012;143(4): 913-916.e7.
6. Bäckhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004;101(44):15718-15723.
7. Jernberg C, Löfmark S, Edlund C, Jansson JK. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 2007;1(1):56-66.
8. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci. 2010;108(Suppl 1):4554-4561.
9. Jakobsson HE, Jernberg C, Andersson AF, Sjölund-Karlsson M, Jansson JK, Engstrand L. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS ONE. 2010;5(3):e9836.
10. Thuny F, Richet H, Casalta J-P, Angelakis E, Habib G, Raoult D. Vancomycin treatment of infective endocarditis is linked with recently acquired obesity. PLoS One. 2010;5(2):e9074.
11. Trasande L, Blustein J, LiuM,Corwin E,CoxLM,Blaser MJ. Infant antibiotic exposures and early-life body mass. Int J Obes. 2013; 37(1):16-23.
12. Bailey LC, Forrest CB, Zhang P, Richards TM, Livshits A, DeRusso PA. Association of antibiotics in infancy with early childhood obesity. JAMA Pediatr. 2014;168(11):1063-1069.
13. ChouH-W,WangJ-L, Chang C-H, Lee J-J, ShauW-Y,Lai M-S. Risk of severe dysglycemia among diabetic patients receiving levofloxacin, ciprofloxacin, or moxifloxacin in Taiwan. Clin Infect Dis. 2013; 57(7):971-980.
14. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39(7 Suppl):30-33.
15. Kildemoes HW, Sørensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39(7 Suppl):38-41.
16. WHO. Collaborating Centre for Drug Statistics Methodology. Guidelines forATCclassification andDDDassignment 2011. Oslo, Norway; 2010.
17. Pedersen CB. The Danish Civil Registration System. Scand J Public Health. 2011;39(7 Suppl):22-25.
18. Sortsø C, Thygesen LC, Brønnum-Hansen H. Database on Danish population-based registers for public health and welfare research. Scand J Public Health. 2011;39(7 Suppl):17-19.
19. Mor A, Berencsi K, Svensson E, et al. Prescribing practices and clinical predictors of glucose-lowering therapy within the first year in people with newly diagnosed type 2 diabetes. Diabet Med. 2015. doi:10.1111/dme.12819.
20. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2012.
21. Charlson ME, Pompei P, Ales KL, MacKenzie CR.Anew method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
22. Thygesen LC, Daasnes C, Thaulow I, Brønnum-Hansen H. Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving. Scand J Public Health. 2011;39(7 Suppl):12-16.
23. Carstensen B, Kristensen JK, Ottosen P, Borch-Johnsen K, on behalf of the steering group of the National Diabetes Register. The Danish National Diabetes Register: trends in incidence, prevalence and mortality. Diabetologia. 2008;51(12):2187-2196.
24. de Vegt F, Dekker JM, Jager A, et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a dutch population: The Hoorn study. JAMA. 2001;285(16):2109-2113.
25. Falagas ME, Kompoti M. Obesity and infection. Lancet Infect Dis. 2006;6(7):438-446.
26. Boursi B, Mamtani R, Haynes K, Yang Y-X. The effect of past antibiotic exposure on diabetes risk. Eur J Endocrinol. 2015;172(6): 639-648.
27. Vrieze A, Out C, Fuentes S, et al. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. J Hepatol. 2014;60(4):824-831.
28. Marchant MH, Viens NA, Cook C, Vail TP, Bolognesi MP. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint SurgAm. 2009; 91(7):1621-1629.
29. Nitzan O, Elias M, Chazan B, Saliba W. Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management. Diabetes Metab Syndr Obes. 2015;8:129-136.
30. Wukich DK, Crim BE, Frykberg RG, Rosario BL. Neuropathy and poorly controlled diabetes increase the rate of surgical site infection after foot and ankle surgery. J Bone Joint Surg Am. 2014;96(10): 832-839.
31. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B. Impaired leucocyte functions in diabetic patients. Diabet Med. 1997;14(1):29-34.
32. Cho I, Yamanishi S, Cox L, et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature. 2012;488 (7413):621-626.
33. Carvalho BM, Guadagnini D, Tsukumo DML, et al. Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice. Diabetologia. 2012;55(10):2823-2834.
34. Membrez M, Blancher F, Jaquet M, et al. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J. 2008;22(7):2416-2426.
35. Wichmann A, Allahyar A, Greiner TU, et al. Microbial modulation of energy availability in the colon regulates intestinal transit. Cell Host Microbe. 2013;14(5):582-590.
36. DeSá Del Fiol F, Tardelli FerreiraACM,Marciano JJ, MarquesMC, Sant'Ana LL. Obesity and the use of antibiotics and probiotics in rats. Chemotherapy. 2015;60(3):162-167.
37. Cox LM, Yamanishi S, Sohn J, et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell. 2014;158(4):705-721.
38. Hwang I, Park YJ, Kim Y-R, et al. Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon-like peptide 1 in diet-induced obesity. FASEB J. 2015;29(6): 2397-2411.
39. Blaser MJ. The Jeremiah Metzger Lecture: Global warming redux: The disappearing microbiota and epidemic obesity. Trans Am Clin Climatol Assoc. 2012;123:230-241.
40. Dibner JJ, Richards JD. Antibiotic growth promoters in agriculture: history and mode of action. Poult Sci. 2005;84(4):634-643.